spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

4th Annual Formulation & Drug Delivery Congress

8-9 May 2018
London, UK

Oxford Global are proud to present our hugely popular 4th Annual Formulation & Drug Delivery Congress, 8th – 9th May 2018, London, UK.Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery.

Including 5 interactive streams:

  • Large Molecule Drug Formulation
  • Advances in Drug Delivery
  • Drug Delivery Devices
  • Small Molecule Drug Formulation
  • Bioanalysis and Stabilisation

Featuring exclusive presentations on regulatory updates and targeted therapies

Co-located with the 3rd Annual Inhalation & Respiratory Drug Delivery Congress covering the development and formulation of inhaled therapies and inhalation devices & analytics.

View the Agenda here: http://bit.ly/2zFQHzn


Free Pre-Congress Webinar Recordings

Advances in Small Drugs Formulation Research
David Elder, Director, Product Development, GlaxoSmithKline & René Holm, Senior Director, Pharmaceutical Science, H. Lundbeck A/S

Download today for free: http://bit.ly/2zD5R8v

API Physical Form Selection: Chances vs Challenges For Formulation Development

Axel Becker, Senior Scientist, Merck KGaA

Download today for free: http://bit.ly/2hvgW0H

For further information, prices & discounts please contact g.alonso@oxfordglobal.co.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>


News and Press Releases

Nemera acquires Insight Product Development to strengthen its capabilities

“Every day at Nemera, we work to improve the lives of millions of patients worldwide by designing, developing and manufacturing innovative drug delivery devices. Our vision as a team is to become the most patient-centric drug delivery device company in the industry. We partner closely with our customers to deliver innovative and high quality devices, to ensure that patients will receive the best product and service possible” Marc Hämel, CEO
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement